Presight Capital — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesPsyMed VenturesRA Capital+6 more
A dairy-free plant-based protein shake brand that sells nutritional beverages for consumers seeking plant-based alternatives to traditional protein products.
ConsumerDirect to ConsumerFoodTechWellness & Fitness
Co-investorsLever VCBig Idea VenturesKale UnitedNucleus CapitalRoute 66 VenturesStray Dog Capital
Una Brands acquires and operates e-commerce brands across Asia, running them under a single house-of-brands model with combined East-West retail practices and AI-led operations.
ConsumerE-commerceRetail TechSingapore, SG
Adrian JohnstoninKiren TannainKushal PatelinShrinivasan ShridharanJonathan Herman
Co-investors500 GlobalCapria VenturesWhite Star Capital468 CapitalAlpha JWC VenturesClaret Capital Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.